Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Option Care Health, Inc.BIOS · Entity 4126 | Director | June 03, 2019 | June 05, 2019 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director | June 11, 2020 | June 15, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Option Care Health, Inc.
Report date June 03, 2019 · Filed June 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Cash-Settled Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 18,905 |
Reported balance
After 2019-06-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-03 · Grant · Acquired 18,905 · Balance 18,905 F1: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date. F2: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date.
F2: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date.
Teladoc Health, Inc.
Report date June 11, 2020 · Filed June 15, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2020-06-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-06-11 · Exercise / conversion · Acquired 7,689 · Balance 7,689 Row 2 · 2020-06-11 · Sale · Disposed 7,689 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 5, 2020. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.50 · Expires 2027-05-25 | Direct | 0 |
Reported balance
After 2020-06-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-06-11 · Exercise / conversion · Disposed 7,689 · Balance 0 F2: The option vested in full on May 25, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 5, 2020.
F2: The option vested in full on May 25, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2020 Filed Jun 15, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 7,689 | $0.00 Strike: $30.50 | $0.00 |
DisclosureSEC source: 0001179110-20-007344 · edgar.xml · derivative · entry 3 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,689 shares Expires 2027-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on May 25, 2018. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 7,689 | $180.00 | $1,384,020.00 |
DisclosureSEC source: 0001179110-20-007344 · edgar.xml · nonDerivative · entry 2 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 5, 2020. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,689 | $30.50 | $234,514.50 |
DisclosureSEC source: 0001179110-20-007344 · edgar.xml · nonDerivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $16.64 | $0.00 |
DisclosureSEC source: 0001179110-20-007009 · edgar.xml · derivative · entry 3 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2026-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on May 24, 2017. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 8,000 | $163.00 | $1,304,000.00 |
DisclosureSEC source: 0001179110-20-007009 · edgar.xml · nonDerivative · entry 2 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 5, 2020. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 8,000 | $16.64 | $133,120.00 |
DisclosureSEC source: 0001179110-20-007009 · edgar.xml · nonDerivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006746 · edgar.xml · derivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,049 Underlying: Common Stock · 1,049 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 28, 2021 and (ii) the day immediately preceding the issuer's 2021 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 28, 2021 and (ii) the day immediately preceding the issuer's 2021 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 1,700 | $0.00 Strike: $16.64 | $0.00 |
DisclosureSEC source: 0001179110-20-004927 · edgar.xml · derivative · entry 6 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 1,700 shares Expires 2026-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in full on May 24, 2017. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 13,105 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001179110-20-004927 · edgar.xml · derivative · entry 5 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,105 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 14,805 | $169.13 | $2,503,969.65 |
DisclosureSEC source: 0001179110-20-004927 · edgar.xml · nonDerivative · entry 4 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 29, 2020. F2 · price: Represents the weighted average price of transactions ranging from $166.00 to $171.06. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 918 | $165.93 | $152,323.74 |
DisclosureSEC source: 0001179110-20-004927 · edgar.xml · nonDerivative · entry 3 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,805 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 29, 2020. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,700 | $16.64 | $28,288.00 |
DisclosureSEC source: 0001179110-20-004927 · edgar.xml · nonDerivative · entry 2 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 13,105 | $8.71 | $114,144.55 |
DisclosureSEC source: 0001179110-20-004927 · edgar.xml · nonDerivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 21:36 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCash-Settled Restricted Stock Unit · Derivative | 18,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020918 · form4.xml · derivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,905 Underlying: Common Stock, $.0001 Par Value · 18,905 shares Expires not disclosed F1 · derivative.exercise_price: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date. F2 · derivative.exercise_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date. F2 · derivative.expiration_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 3,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006971 · edgar.xml · derivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,012 Underlying: Common Stock · 3,012 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 30, 2020 and (ii) the day immediately preceding the issuer's 2020 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 30, 2020 and (ii) the day immediately preceding the issuer's 2020 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 16:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 20,500 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001179110-19-003511 · edgar.xml · derivative · entry 4 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,105 Underlying: Common Stock · 20,500 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 16:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,000 | $63.47 | $634,700.00 |
DisclosureSEC source: 0001179110-19-003511 · edgar.xml · nonDerivative · entry 3 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918 F2 · price: Represents the weighted average price of transactions ranging from $63.39 to $63.56. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 16:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,500 | $63.33 | $664,965.00 |
DisclosureSEC source: 0001179110-19-003511 · edgar.xml · nonDerivative · entry 2 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,918 F1 · price: Represents the weighted average price of transactions ranging from $63.25 to $63.61. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 16:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 20,500 | $8.71 | $178,555.00 |
DisclosureSEC source: 0001179110-19-003511 · edgar.xml · nonDerivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 17:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007973 · edgar.xml · derivative · entry 2 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,965 Underlying: Common Stock · 1,965 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F1 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F1 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 17:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantStock Option (right to buy) · Derivative | 4,082 | $0.00 Strike: $50.90 | $0.00 |
DisclosureSEC source: 0001179110-18-007973 · edgar.xml · derivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,082 Underlying: Common Stock · 4,082 shares Expires 2028-05-31 F2 · derivative.exercise_date: The option vests in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Read SEC document |
| May 25, 2018 Filed May 30, 2018 16:55 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007678 · edgar.xml · derivative · entry 2 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 918 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 918 restricted stock units, vesting in full on May 25, 2018. F2 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 918 restricted stock units, vesting in full on May 25, 2018. Read SEC document |
| May 25, 2018 Filed May 30, 2018 16:55 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-007678 · edgar.xml · nonDerivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:57 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCommon Stock, $.0001 Par Value | 43,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016495 · form4.xml · nonDerivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,895 F1 · shares: Vests and becomes non-forfeitable on the day before the Company's 2019 Annual Meeting. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 17:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 12,249 | $0.00 Strike: $10.84 | $0.00 |
DisclosureSEC source: 0001179110-18-003667 · edgar.xml · derivative · entry 5 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,249 shares Expires 2026-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on May 26, 2017. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 17:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 54,325 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001179110-18-003667 · edgar.xml · derivative · entry 4 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,605 Underlying: Common Stock · 54,325 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 17:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 66,574 | $39.72 | $2,644,319.28 |
DisclosureSEC source: 0001179110-18-003667 · edgar.xml · nonDerivative · entry 3 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 17:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 12,249 | $10.84 | $132,779.16 |
DisclosureSEC source: 0001179110-18-003667 · edgar.xml · nonDerivative · entry 2 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 17:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 54,325 | $8.71 | $473,170.75 |
DisclosureSEC source: 0001179110-18-003667 · edgar.xml · nonDerivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2017 Filed May 30, 2017 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008230 · edgar.xml · derivative · entry 2 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918 Underlying: Common Stock · 918 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 25, 2018 and (ii) the day immediately preceding the issuer's 2018 annual meeting of stockholders. F3 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 25, 2018 and (ii) the day immediately preceding the issuer's 2018 annual meeting of stockholders. Read SEC document |
| May 25, 2017 Filed May 30, 2017 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantStock Option (right to buy) · Derivative | 7,689 | $0.00 Strike: $30.50 | $0.00 |
DisclosureSEC source: 0001179110-17-008230 · edgar.xml · derivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,689 Underlying: Common Stock · 7,689 shares Expires 2027-05-25 F1 · derivative.exercise_date: The option vests in full on the earlier of (i) May 25, 2018 and (ii) the day immediately preceding the issuer's 2018 annual meeting of stockholders. Read SEC document |
| May 02, 2017 Filed May 4, 2017 16:55 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCommon Stock, $.0001 Par Value | 49,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016825 · form4.xml · nonDerivative · entry 1 GOLDSTEIN MICHAEL · CIK 0001043027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,169 F1 · shares: Vests and becomes non-forfeitable on the day before the Company's 2018 Annual Meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.